Although InvEE keratinocytes express elevated levels of IL-1α and administration of the IL-1 receptor antagonist Kineret decreases tumour formation8, 9, no differences in wound-induced tumour formation were observed between IL-1R1−/− BM and control chimeras (Fig. 3b). This evidence concerns the gene IL1A and neoplasm.